Literature DB >> 4735455

The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis.

L I Landau, P D Phelan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4735455     DOI: 10.1016/s0022-3476(73)80085-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  10 in total

Review 1.  Airway reactivity in cystic fibrosis.

Authors:  R S Tepper; H Eigen
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.

Authors:  D A Spencer
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.

Authors:  S P Conway; A Watson
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

4.  Variable response to inhaled salbutamol of different lung function parameters in healthy children.

Authors:  F Riedel; H von der Hardt
Journal:  Lung       Date:  1986       Impact factor: 2.584

5.  Atopy and bronchial reactivity in older patients with cystic fibrosis.

Authors:  M J Tobin; O Maguire; D Reen; E Tempany; M X Fitzgerald
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

Review 6.  Airways reactivity in patients with CF.

Authors:  Miles Weinberger
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Association of cystic fibrosis with allergy.

Authors:  J O Warner; B W Taylor; A P Norman; J F Soothill
Journal:  Arch Dis Child       Date:  1976-07       Impact factor: 3.791

8.  Variability of airways hyper-reactivity and allergy in cystic fibrosis.

Authors:  F J Holzer; A Olinsky; P D Phelan
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

9.  Cystic fibrosis, atopy, and airways lability.

Authors:  M Silverman; F D Hobbs; I R Gordon; F Carswell
Journal:  Arch Dis Child       Date:  1978-11       Impact factor: 3.791

10.  Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis.

Authors:  M Kattan; A Mansell; H Levison; M Corey; I R Krastins
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.